CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1 target
Drug / intervention
Exposed to Arepanrix™ Cohort +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02367222
NCT02367222N/ACompleted
CompareCT.gov

An Observational Retrospective Database Analysis to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada

University of Manitoba·observational·Posted Feb 20, 2015·Updated May 12, 2016

In Brief

An observational study evaluating Exposed to Arepanrix™ Cohort and Unexposed to Arepanrix™ Cohort for Multiple Sclerosis. Completed, enrolled 1 participant.

Detailed Summary

The purpose of this database study is to assess if Arepanrix™ vaccination during the 2009 pandemic was associated with an increased risk of multiple sclerosis (MS) in Manitoba, Canada.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis
Countries--
CollaboratorsGlaxoSmithKline

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 20, 2015
Enrollment StartAug 1, 2014
Primary CompletionAug 1, 2015
Study CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 11.4 years ago

Interventions

Exposed to Arepanrix™ Cohortother

Demographic characteristics such as age, sex, area of residence, socio-economic status; medical history such as comorbidities, immune status, vaccine indication, receipt of other vaccines or medications and frequency of healthcare contacts, as well as information on pregnancy status and pre-existing conditions will be collected..

Unexposed to Arepanrix™ Cohortother

Demographic characteristics such as age, sex, area of residence, socio-economic status; medical history such as comorbidities, immune status, vaccine indication, receipt of other vaccines or medications and frequency of healthcare contacts, as well as information on pregnancy status and pre-existing conditions will be collected.